Laddar...
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial surface receptor genetically linked to the risk for Alzheimer’s disease (AD). A proteolytic product, soluble TREM2 (sTREM2), is abundant in the cerebrospinal fluid and its levels positively correlate with neuronal injury marker...
Sparad:
| I publikationen: | Nat Commun |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6433910/ https://ncbi.nlm.nih.gov/pubmed/30911003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-019-09118-9 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|